院内卒中再灌注治疗研究进展  

Progress of Reperfusion Therapy for In-hospital Stroke

作　　者：刘子悦 朱以诚 LIU Ziyue;ZHU Yicheng(Department of Neurology,State Key Laboratory of Complex Severe and Rare Diseases,Peking Union Medical College Hospital,Chinese Academy of Medical Science&Peking Union Medical College,Beijing 100730,China)

机构地区：[1]中国医学科学院,北京协和医学院,北京协和医院神经科/疑难重症及罕见病国家重点实验室,北京100730

出　　处：《中国卒中杂志》2022年第7期695-705,共11页Chinese Journal of Stroke

摘　　要：院内卒中患者虽然卒中发病时置身医院环境,但由于其基础病情复杂、识别困难、治疗禁忌证多等因素,存在再灌注治疗延迟和再灌注率低等情况,是导致院内卒中预后不良的重要因素。针对院内卒中再灌注治疗流程中不同环节的延误原因,加强院内卒中识别、改进溶栓绿色通道流程、重视头颅影像学中灌注成像检查等措施有利于改善院内卒中再灌注治疗的延误。我国院内卒中救治体系尚未完善,未来需结合我国国情、院内卒中的特征以及先进中心的经验,加强绿色通道诊治流程建设和改良,以改善院内卒中患者的预后。Reperfusion therapy for in-hospital stroke is frequently absent or delayed,due to complex underlying disease,difficulties in recognition and contraindications,which are the major factors contributing to poor prognosis of in-hospital stroke.Some intervenes addressing delays in different sections of stroke fast tract have been proved to improve the in-hospital stroke reperfusion processes.The system of in-hospital stroke care in China have not yet been perfected.Thus,it is necessary refine the workflow of stroke fast tract according to China's national conditions,characteristics of in-hospital stroke and the experience of advanced centers,in order to improve the prognosis of patients with in-hospital stroke.

关 键 词：院内卒中 缺血性卒中 再灌注治疗 绿色通道 

分 类 号：R743.3[医药卫生—神经病学与精神病学]